On the other hand, several PRRs also have been proved to inhibit tumor progression, such as deficiency of retinoic acid-inducible gene-I (RIG-I) can promote hepatocellular carcinoma (HCC) carcinogenesis (7). This evidence concerns the gene RIGI and neoplasm.